BioCentury | May 19, 2020
Finance

May 19 Quick Takes: Cowen closes $493M fund; plus Guangzhou BeBetter, Fountain Therapeutics, Amplyx, ChromaCode, Applied Molecular

...treat and prevent BK viral disease in transplant patients. ChromaCode adds $10M to series C ChromaCode Inc....
...biologics to treat autoimmune, inflammatory and metabolic diseases. BioCentury Staff Guangzhou BeBetter Medicine Technology Co. Ltd. Amplyx Pharmaceuticals Inc. ChromaCode Inc. Applied...
Items per page:
1 - 1 of 1
BioCentury | May 19, 2020
Finance

May 19 Quick Takes: Cowen closes $493M fund; plus Guangzhou BeBetter, Fountain Therapeutics, Amplyx, ChromaCode, Applied Molecular

...treat and prevent BK viral disease in transplant patients. ChromaCode adds $10M to series C ChromaCode Inc....
...biologics to treat autoimmune, inflammatory and metabolic diseases. BioCentury Staff Guangzhou BeBetter Medicine Technology Co. Ltd. Amplyx Pharmaceuticals Inc. ChromaCode Inc. Applied...
Items per page:
1 - 1 of 1